Cargando…

Tocilizumab and Systemic Corticosteroids in the Management of Patients with COVID-19: A Systematic Review and Meta-Analysis

BACKGROUND: To date, there is no effective treatment for the new coronavirus disease (COVID-19). We aimed to systematically review the literature on the association between the combination of tocilizumab (TCZ) and systemic corticosteroid therapy (SCT) on outcomes of COVID-19 patients. METHODS: We se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alkofide, Hadeel, Almohaizeie, Abdullah, Almuhaini, Sara, Alotaibi, Bashayer, Alkharfy, Khalid M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278842/ https://www.ncbi.nlm.nih.gov/pubmed/34273515 http://dx.doi.org/10.1016/j.ijid.2021.07.021

Ejemplares similares

Candidemia in COVID‐19 treated with corticosteroids and tocilizumab
por: Yamamoto, Koichiro, et al.
Publicado: (2021)

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis
por: Zeraatkar, Dena, et al.
Publicado: (2022)

Comparing the efficacy of tocilizumab with corticosteroid therapy in treating COVID-19 patients: a systematic review and meta-analysis
por: Lim, Phei Ching, et al.
Publicado: (2022)

The Use of Corticosteroids or Tocilizumab in COVID-19 Based on Inflammatory Markers
por: Rubio-Rivas, Manuel, et al.
Publicado: (2021)

Knowledge, Attitude, and Practice Towards COVID-19 Among Pharmacists: A Cross-Sectional Study
por: AlRasheed, Maha M, et al.
Publicado: (2021)

Tocilizumab as treatment for COVID-19: A systematic review and meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2021)

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis
por: Albuquerque, Arthur M., et al.
Publicado: (2023)

Corticosteroid Plus Tocilizumab in COVID-19: When Two Is Better Than One
por: Kow, Chia Siang, et al.
Publicado: (2021)

Covid-19 Vaccine Surveillance in Saudi Arabia: Opportunities for Real-time Assessment
por: Albogami, Yasser, et al.
Publicado: (2021)

A Case of Abdominal Perforation in a COVID+ Patient Treated With Tocilizumab and Corticosteroids
por: Chaudhry, Bilal, et al.
Publicado: (2023)

Thromboprophylaxis in Hospitalized Non-Critically Ill Patients With Mild-to-Moderate COVID-19 Infection: A Systematic Review and Meta-Analysis
por: Hafiz, Awatif, et al.
Publicado: (2023)

A Recovered Case of COVID-19 Myocarditis and ARDS Treated With Corticosteroids, Tocilizumab, and Experimental AT-001
por: Coyle, Justin, et al.
Publicado: (2020)

Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19()
por: Kawamata, Takaya, et al.
Publicado: (2022)

Tocilizumab in Combination with Corticosteroids in COVID-19 Pneumonia: A Single-Centre Retrospective Controlled Study
por: Kardos, Zsófia, et al.
Publicado: (2023)

Tocilizumab for severe COVID-19: a systematic review and meta-analysis
por: Lan, Shao-Huan, et al.
Publicado: (2020)

Pulse Therapy With Corticosteroids and Intravenous Immunoglobulin in the Management of Severe Tocilizumab-Resistant COVID-19: A Report of Three Clinical Cases
por: Sheianov, Mikhail V, et al.
Publicado: (2020)

Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome
por: Segú-Vergés, Cristina, et al.
Publicado: (2023)

Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia
por: AlQahtani, Hajar, et al.
Publicado: (2022)

Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness
por: Rubio-Rivas, Manuel, et al.
Publicado: (2020)

Intestinal perforation in patient with COVID-19 infection treated with tocilizumab and corticosteroids. Report of a clinical case()
por: Gonzálvez Guardiola, Paula, et al.
Publicado: (2021)

Impact of the Addition of Baricitinib to Standard of Care Including Tocilizumab and Corticosteroids on Mortality and Safety in Severe COVID-19
por: Masiá, Mar, et al.
Publicado: (2021)

Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis
por: Wei, Qiu, et al.
Publicado: (2021)

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
por: Rodríguez-Baño, Jesús, et al.
Publicado: (2021)

Tocilizumab/unspecified corticosteroids: Spinal epidural abscess: 2 case report
Publicado: (2020)

Long‐term outcomes in corticosteroid‐refractory Graves' orbitopathy treated with tocilizumab
por: Moi, Laura, et al.
Publicado: (2021)

Potentially Inappropriate Medications Use among Older Adults with Dyslipidaemia
por: Alwhaibi, Monira, et al.
Publicado: (2023)

Mortality Rates Among Hospitalized Patients With COVID-19 Infection Treated With Tocilizumab and Corticosteroids: A Bayesian Reanalysis of a Previous Meta-analysis
por: Albuquerque, Arthur M., et al.
Publicado: (2022)

Date of Admission during COVID-19 Pandemic Impacted Patient Outcomes in Addition to the Higher Efficacy of Tocilizumab Plus High-Dose Corticosteroid Therapy Compared to Tocilizumab Alone
por: Belhassen-García, Moncef, et al.
Publicado: (2021)

Case Study: A Patient with Asthma, Covid-19 Pneumonia and Cytokine Release Syndrome Treated with Corticosteroids and Tocilizumab
por: Schleicher, Gunter K, et al.
Publicado: (2020)

Tocilizumab in addition to standard of care in the management of COVID-19: a meta-analysis of RCTs
por: Mutua, Victor, et al.
Publicado: (2022)

Use of Tocilizumab in COVID-19: A Systematic Review and Meta-Analysis of Current Evidence
por: Kotak, Sohny, et al.
Publicado: (2020)

Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19)
por: Chen, Chong-xiang, et al.
Publicado: (2021)

Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
por: González-Castro, A., et al.
Publicado: (2022)

The use of enoxaparin as venous thromboembolism prophylaxis in bariatric surgery: A retrospective cohort study
por: Altawil, Esraa, et al.
Publicado: (2022)

Tocilizumab in the Management of COVID-19: A Preliminary Report
por: Li, Michael, et al.
Publicado: (2021)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study
por: López-Medrano, Francisco, et al.
Publicado: (2021)

Corticosteroids on the Management of Coronavirus Disease 2019 (COVID-19): A Systemic Review and Meta-Analysis
por: YOUSEFIFARD, Mahmoud, et al.
Publicado: (2020)

Tocilizumab for treating COVID-19: a systemic review and meta-analysis of retrospective studies
por: Zhao, Meng, et al.
Publicado: (2020)

Tocilizumab, Adipokines and Severe Complications of COVID-19
por: Fioravanti, Antonella, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gcdsmm1s7bjldhga6tilsap0j0